
<http://bio2rdf.org/drugbank:DB00031> a <http://schema.org/Drug> ;
	<http://schema.org/name> "Tenecteplase" ;
	<http://schema.org/description> "Tissue plasminogen activator (tPA). Tenecteplase is a 527 amino acid glycoprotein developed by introducing the following modifications to the complementary DNA (cDNA) for natural human tPA: a substitution of threonine 103 with asparagine, and a substitution of asparagine 117 with glutamine, both within the kringle 1 domain, and a tetra-alanine substitution at amino acids 296-299 in the protease domain." ;
	<http://schema.org/url> "https://www.drugbank.ca/drugs/DB00031" ;
	<http://schema.org/doseSchedule> "50 mg Powder for solution form with intravenous route" ;
	<http://schema.org/legalStatus> "approved" ;
	<http://schema.org/mechanismOfAction> "Tenecteplase binds to fibrin rich clots via the fibronectin finger-like domain and the Kringle 2 domain. The protease domain then cleaves the Arg/Val bond in plasminogen to form plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action." ;
	<http://schema.org/alternateName> "Tissue-type plasminogen activator precursor" ;
	<http://schema.org/sameAs> "https://www.drugbank.ca/drugs/DB00031" .
